Managing the myelotoxicity of CHOP chemotherapyBRUSAMOLINO, Ercole.European journal of cancer. Supplement (1990). 2008, Vol 6, Num 2, pp 31-36, issn 1359-6349, 6 p.Conference Paper

Supravenous hyperpigmentation in association with CHOP chemotherapy of a CD30 (Ki-1)-positive anaplastic large-cell lymphomaSCHULTE-HUERMANN, P; ZUMDICK, M; RUZICKA, T et al.Dermatology (Basel). 1995, Vol 191, Num 1, pp 65-67, issn 1018-8665Article

Phase III trial of CHOP-21 versus CHOP-14 for aggressive non-Hodgkin's lymphoma: final results of the Japan Clinical Oncology Group Study, JCOG 9809OHMACHI, K; TOBINAI, K; AIKAWA, K et al.Annals of oncology. 2011, Vol 22, Num 6, pp 1382-1391, issn 0923-7534, 10 p.Article